Xtant Medical Holdings (FRA:XMS) Effective Interest Rate on Debt %: 10.94% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XMS Xtant Medical Holdings Inc FRA:XMS
27 GF Score
Price €0.39
GF Value €0.54
! 4 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Effective Interest Rate on Debt %?

Xtant Medical Holdings FRA:XMS +11.36% 27 Effective Interest Rate on Debt % is 10.94% as of Mar. 2026. GuruFocus rates FRA:XMS with a GF Score™ of 27/100 and a GF Value™ of €0.54. The stock has 4 warning signs investors should review.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Xtant Medical Holdings's annualized positive value of Interest Expense for the quarter that ended in Mar. 2026 was €2.1 Mil. Xtant Medical Holdings's average total debt for the quarter that ended in Mar. 2026 was €18.9 Mil. Therefore, Xtant Medical Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 was 10.94%.


Xtant Medical Holdings  (FRA:XMS) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Xtant Medical Holdings Effective Interest Rate on Debt % Related Terms


Xtant Medical Holdings Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Effective Interest Rate on Debt % Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.84 10.30 14.28 14.40 10.79

Xtant Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.85 10.90 10.30 9.39 10.94

FRA:XMS vs POSC, LUNG, MDAI: Effective Interest Rate on Debt % Comparison

For the Medical Devices subindustry, Xtant Medical Holdings's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings Effective Interest Rate on Debt % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Effective Interest Rate on Debt % falls into.


FRA:XMS
27GF Score
Xtant Medical Holdings Inc FRA:XMS
Effective Interest Rate on Debt % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Effective Interest Rate on Debt % Calculation

Xtant Medical Holdings's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2024 )+Total Debt  (A: Dec. 2025 ))/ count )
=-1  *  -3.135/( (33.562+24.524)/ 2 )
=-1  *  -3.135/29.043
=10.79 %

where

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=21.25 + 12.312
=33.562

Total Debt  (A: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=11.702 + 12.822
=24.524

Xtant Medical Holdings's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2025 )+Total Debt  (Q: Mar. 2026 ))/ count )
=-1  *  -2.072/( (24.524+13.352)/ 2 )
=-1  *  -2.072/18.938
=10.94 %

where

Total Debt  (Q: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=11.702 + 12.822
=24.524

Total Debt  (Q: Mar. 2026 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=9.189 + 4.163
=13.352

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2026) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 10.94% mean?
Xtant Medical Holdings (FRA:XMS) has a Effective Interest Rate on Debt % of 10.94% as of Mar. 2026. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Xtant Medical Holdings and its competitors.
Is Xtant Medical Holdings' Effective Interest Rate on Debt % too high?
Xtant Medical Holdings' current Effective Interest Rate on Debt % is 10.94%. Overall, Xtant Medical Holdings has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' Effective Interest Rate on Debt % compare to POSC and LUNG?
Xtant Medical Holdings' Effective Interest Rate on Debt % of 10.94% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Medical Devices & Instruments company?
A good Effective Interest Rate on Debt % depends on the Medical Devices & Instruments industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Xtant Medical Holdings and its competitors. Xtant Medical Holdings's current Effective Interest Rate on Debt % is 10.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Xtant Medical Holdings (FRA:XMS) has a current Effective Interest Rate on Debt % of 10.94%. The stock's GF Value™ is €0.54, compared to a current price of €0.39 — trading 27.4% below its estimated fair value. The current Effective Interest Rate on Debt % is 10.94%. Xtant Medical Holdings' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Xtant Medical Holdings (FRA:XMS), the current Effective Interest Rate on Debt % is 10.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xtant Medical Holdings (FRA:XMS) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of €0.39 is trading 27.4% below its estimated GF Value™ of €0.54.

Key valuation signals for FRA:XMS:

  • Effective Interest Rate on Debt %: 10.94%
  • GF Value™: €0.54 vs. price of €0.39 (27.4% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the FRA:XMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xtant Medical Holdings Business Description

Other Exchanges XTNT:USA
Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
27GF Score

Get the complete analysis for FRA:XMS

Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.39
Price
€0.54
GF Value